Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cancer related cognitive impairments have been subjectively reported and objectively detected in breast cancer patients treated with chemotherapy and are known to have a profound negative impact on productivity, psychosocial well-being and overall quality of life. Moderate levels of walking are known to be of benefit to the psychosocial well-being of those affected by breast cancer and for managing cognitive impairment in healthy adults, children, and the elderly. The purpose of this study is to investigate the effects of a home-based, self-managed, moderate intensity walking intervention on subjective and objective cognitive functioning in breast cancer patients undergoing chemotherapy. METHODS: A home-based, self-managed intervention that consisted of moderate levels of walking was compared to usual care among breast cancer patients treated with chemotherapy in a randomised controlled trial. Outcome measures included changes in subjective (CFQ) and objectively detected cognitive functioning (Stroop, SART and two subscales from the WAIS- Digit Span and Block Design). Fifty participants were randomised to either the intervention group (n = 25), who completed 12 weeks of moderate intensity walking, or to the control group (n = 25) mid-way through chemotherapy. RESULTS: Compared with the control group, the self-managed walking intervention had positive effects on perceived cognitive function but not on sustained attention, executive function, memory or visual spatial skills when assessed objectively using neuropsychological measures. CONCLUSION: This home-based, self-managed intervention is beneficial for protecting against perceived cognitive decline in breast cancer patients treated with chemotherapy. There is a need for further research to objectively assess cognitive decline within this population with larger sample sizes of patients. TRIAL REGISTRATION: Current Controlled Trials ISRCTN50709297.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The theory of planned behavior
Ajzen, I. (1991) · Organizational Behavior and Human Decision Processes · doi:10.1016/0749-5978(91)90020-t · Cited by 90,587
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., GALVÃO, D. A., Pinto, B. M., IRWIN, M. L., WOLIN, K. Y., SEGAL, R. J., LUCIA, A., et al. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0c112 · Cited by 2,781 · cited 1×
“Walking schedules were self-managed; however, the researcher recommended that participants begin by completing 10 minutes of walking at any one time and then steadily increasing the duration to 30 minutes five times a week, in line with recommended guidelines of 150 minutes of moderate to vigorous intensity exercise p…”
MethodPhysical activity and mental health in children and adolescents: a review of reviews
Biddle, S. J. H., & Asare, M. (2011) · British Journal of Sports Medicine · doi:10.1136/bjsports-2011-090185 · Cited by 2,447 · cited 1×
“In contrast, evidence demonstrates promising effects of easy-moderate levels of walking as a protective strategy for managing cognitive impairment in healthy individuals, and the elderly [40], [41] as assessed by objective measures.”
BackgroundIntention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
A Shortened Version of the Profile of Mood States
Shacham, S. (1983) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4703_14 · Cited by 1,231 · cited 1×
“Assessments of psychosocial well-being included anxiety and depression (Hospital Anxiety and Depression Scale) [49], mood (Profile of Mood States) [50], fatigue (Functional Assessment of Cancer Therapy- Fatigue) [51], and self-esteem (The Self-Esteem Scale) [52].”
MethodVerbal and Visuospatial Short-Term and Working Memory in Children: Are They Separable?
Alloway, T. P., Gathercole, S. E., & Pickering, S. J. (2006) · Child Development · doi:10.1111/j.1467-8624.2006.00968.x · Cited by 938 · cited 1×
“One argument suggests that, unlike forwards recall, backwards recall involves executive control and may be considered as a complex span measure of working memory [80].”
BackgroundHillman, C. H., Pontifex, M. B., Raine, L. B., Castelli, D. M., Hall, E. E., & Kramer, A. F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.01.057 · Cited by 845
Statistics notes: How to randomise
Altman, D. G., & Bland, J. M. (1999) · BMJ · doi:10.1136/bmj.319.7211.703 · Cited by 506
Accelerometers and pedometers: methodology and clinical application
Corder, K., Brage, S., & Ekelund, U. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328285d883 · Cited by 339 · cited 1×
“In line with previous findings, seven days of continuous monitoring is recommended to assess habitual physical activity in adults and provides a tradeoff between feasibility, reliability and acceptable participant burden [66].”
ResultCognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.004 · Cited by 300 · cited 1×
“Mixed effects on objective cognitive function have been found post-treatment in breast cancer survivors, through the implementation of cognitive behavioural training [26], memory and health training [30], cognitive training [27], [29] and physical activity [32], [33], [36], [38], [39].”
BackgroundWallis, D. J., & Hetherington, M. M. (2004) · Appetite · doi:10.1016/j.appet.2004.02.001 · Cited by 278 · cited 1×
“A computerised version of the Stroop task [53] was used to measure executive function in two blocks.”
MethodSelf-citationHartman, S. J., Nelson, S. H., Myers, E., Natarajan, L., Sears, D. D., Palmer, B. W., Weiner, L. S., Parker, B. A., & Patterson, R. E. (2018) · Cancer · doi:10.1002/cncr.30987 · Cited by 188 · cited 1×
“Mixed effects on objective cognitive function have been found post-treatment in breast cancer survivors, through the implementation of cognitive behavioural training [26], memory and health training [30], cognitive training [27], [29] and physical activity [32], [33], [36], [38], [39].”
BackgroundCancer, cognitive impairment, and meditation
Biegler, K. A., Alejandro Chaoul, M., & Cohen, L. (2009) · Acta Oncologica · doi:10.1080/02841860802415535 · Cited by 111
Callaghan, P., Khalil, E., Morres, I., & Carter, T. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-465 · Cited by 105
van Waart, H., van Harten, W. H., Buffart, L. M., Sonke, G. S., Stuiver, M. M., & Aaronson, N. K. (2016) · Psycho-Oncology · doi:10.1002/pon.3936 · Cited by 95 · cited 1×
“The 80% adherence rate to the intervention is noteworthy and a strength of the self-managed, home-based intervention in line with previous evidence which reported that over 50% of breast cancer patients prefer to exercise alone [84].”
Result
Cited by
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
Ligibel, J. A., Bohlke, K., May, A. M., Clinton, S. K., Demark-Wahnefried, W., Gilchrist, S. C., Irwin, M. L., Late, M., Mansfield, S., Marshall, T. F., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00687 · Cited by 700
Oldacres, L., Hegarty, J., O'Regan, P., Murphy‐Coakley, N. M., & Saab, M. M. (2023) · Psycho-Oncology · doi:10.1002/pon.6073 · Cited by 36
Metadata
- Authors
- Gokal, K., Munir, F., Ahmed, S., Kancherla, K., & Wallis, D.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-28
- Volume
- 13
- Issue
- 11
- Pages
- e0206874
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2902944100
- Cited by
- 62
- References
- 16
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.